Study TypeCognitive Impairment & Alzheimer's Disease
Study PurposeThe purpose of the rrAD research study is to assess if exercise, blood pressure medications, or the combination of both could help reduce the risk of developing dementia.
About the Study
Scientists at Pennington Biomedical are working to better understand the potential links between high blood pressure and the risk for developing dementia.
The rrAD research study will evaluate individuals who exhibit a decline in memory or have an immediate family member (parent or sibling) with dementia. The study will enroll participants who do not currently have dementia, but who do have hypertension (high blood pressure) to assess if exercise, blood pressure medications or a combination of both treatments could reduce cognitive decline (memory loss) and reduce the risk of developing dementia.
- 2 screening visits
- 3 introductory visits
- 4 study visits (one every 6 months for a 2 year period)
- 3 follow-up visits
- Additional regularly scheduled exercise visits over the 2 year period may be required.
- Health assessment/vital signs (blood pressure, pulse, etc.)
- Physical and neurological examinations
- Test for heart health (ECG)
- Exercise and physical performance testing
- Blood tests
- Imaging (MRI)
Total number of study visits required for participants in this study:
These visits include:
- Be between the ages of 60-85 years old
- Have concerns about memory loss or have an immediate relative with a diagnosis of dementia
- Have high blood pressure or be on medication for high blood pressure
- Have a primary care physician
To qualify, participants in this study should: